APA (7th ed.) Citation

Lee, J., Chung, Y., Kim, H. R., & Song, J. H. (2025). Efficacy of Tumor Necrosis Factor-α Inhibitor Adalimumab in Chronic Recurrent Vogt–Koyanagi–Harada Disease. Pharmaceuticals (14248247), 18(12), 1848. https://doi.org/10.3390/ph18121848

Chicago Style (17th ed.) Citation

Lee, Junghoo, Yoo-Ri Chung, Hae Rang Kim, and Ji Hun Song. "Efficacy of Tumor Necrosis Factor-α Inhibitor Adalimumab in Chronic Recurrent Vogt–Koyanagi–Harada Disease." Pharmaceuticals (14248247) 18, no. 12 (2025): 1848. https://doi.org/10.3390/ph18121848.

MLA (9th ed.) Citation

Lee, Junghoo, et al. "Efficacy of Tumor Necrosis Factor-α Inhibitor Adalimumab in Chronic Recurrent Vogt–Koyanagi–Harada Disease." Pharmaceuticals (14248247), vol. 18, no. 12, 2025, p. 1848, https://doi.org/10.3390/ph18121848.